SCHEMBL5745758

SCHEMBL5745758

Cc1cc(C)nc(C(CO)c2cc(C)c3nn(COCC[Si](C)(C)C)cc3c2)n1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5745077 0.83 PDE10A (0.33) KLKB1
SCHEMBL5745667 0.82 BRD4 (0.34) KLKB1
SCHEMBL5743215 0.81 DGAT1 (0.32) —
SCHEMBL5747621 0.81 ALDH1A1 (0.33) KLKB1
SCHEMBL4503953 0.80 — —
SCHEMBL5746562 0.80 DGAT1 (0.34) —
SCHEMBL4513129 0.77 GCGR (0.30) —
SCHEMBL5746539 0.77 KDM4E (0.30) —
SCHEMBL2427195 0.77 KLKB1 (0.32) KLKB1
SCHEMBL2426862 0.74 DGAT1 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1689738-A2 HETEROCYCLIC ANTI-MIGRAINE AGENTS Bristol-Myers Squibb Company (US) 2006-08-16 — — EP disclosed
WO-2005056550-A2 HETEROCYCLIC ANTI-MIGRAINE AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-06-23 — — WO disclosed
Send feedback